Gene Query: TBCK

Dataset Description Geneva Score
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 52.04
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 17.89
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 14.83
Changes in human endometrial gland transcriptome over the window of implantation 13.28
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 12.8
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 12.4
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 12.05
RNA sequencing of matched nephrectomy samples [RNA-seq] 12.05
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 11.91
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 11.86
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 11.06
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 10.55
RNAseq Study in CC-671 Treated Cal-51 Cells 10.4
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 10.29
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.67
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 9.58
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 9.58
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 9.14
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 9.12
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 8.59
Transcriptome analysis of H9 hESC derived cerebral organoids 8.29
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 8.18
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 8.17
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 8.1
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 7.91
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 7.72
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 7.72
Electronic cigarettes 7.7
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 7.67
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.12
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 7.08
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 7.03
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 7.03
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 7.02
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 6.7
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 6.7
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 6.65
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 6.65
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 6.65
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.46
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 6.35
BAF controls genome accessibility 6.31
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.29
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 6.19
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 6.19
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 6.09
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 6.09
Differentially expressed genes post knock down of lincDUSP26 6.05
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.01
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 5.99
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 5.99
Toxoplasma gondii infection of human retinal pigment epithelial cells 5.95
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.94
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 5.93
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 5.93
Ebola virus (EBOV) infection of ARPE-19 cells 5.89
Reassessment of Exosome Composition 5.88
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 5.86
Endometrial transcriptome and PGR cistrome in cycling fertile women 5.86
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 5.86
Genome-wide discovery of human splicing branchpoints 5.85
Differential expression of genes in AD169-infected MRC5. 5.85
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.76
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.76
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 5.72
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 5.7
Cleavage Factor Im as a key regulator of 3’ UTR length 5.62
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 5.54
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.32
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.32
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 5.31
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 5.2
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.16
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 5.13
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 5.11
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 5.05
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 5.01
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.94
Differentiation enhances Zika virus infection in neuronal brain cells 4.92
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 4.88
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 4.88
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.87
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 4.83
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 4.83
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 4.76
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 4.76
Primary human trophoblast from term placenta 4.75
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 4.74
Endothelial gene expression analysis 4.72
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.72
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.71
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.71
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.71
RNA-seq of resting and activated CD4+ T cells +-JQ1 4.65
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 4.63
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 4.62
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.61
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 4.56
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 4.52
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 4.43
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 4.42
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.4
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.39
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 4.36
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 4.36
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 4.36
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.35
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 4.26
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 4.26
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 4.21
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 4.19
RNA-seq of young and quiescent MRC-5 human fibroblasts 4.18
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.14
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 4.09
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 4.09
Gene expression in GBM with Cav3.2 inhibition 4.08
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 4.07
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.05
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 4.01
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 3.99
T47D RNA-seq and ChrRNA-seq data 3.99
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 3.99
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 3.95
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.93
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.93
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 3.9
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 3.88
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.83
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 3.81
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 3.81
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.79
ARID1A regulates condensin II distribution and chromosomal partition 3.77
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 3.77
FOXP2's impact on the primate transcriptome 3.73
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 3.73
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 3.72
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 3.72
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 3.7
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 3.69
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.68
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 3.67
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.64
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 3.64
HEXIM1 is induced by DHODH inhibition to suppress melanoma 3.63
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 3.63
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.6
Single-nucleotide-resolution mapping of HBV promoters using CAGE 3.6
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 3.58
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.57
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.57
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.55
Random mono-allelic expression in MECP2-mutated cells 3.55
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.55
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 3.53
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 3.51
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 3.51
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.5
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.5
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 3.48
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 3.47
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.46
Transcriptomic profiling of human peripheral blood-derived mast cells 3.46
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 3.46
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.37
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 3.36
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 3.36
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.32
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 3.31
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 3.31
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 3.29
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 3.29
HNRNPL and its RNA Targets in Prostate Cancer 3.29
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 3.27
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.25
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 3.25
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 3.24
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.24
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 3.22
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 3.22
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 3.2
NRDE2 negatively regulates nuclear exosome functions 3.2
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 3.19
Loss of endometrial plasticity in recurrent pregnancy loss 3.19
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 3.17
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.17
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 3.14
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.14
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.14
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 3.13
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 3.12
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.12
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 3.12
Investigation about fibroblasts of different origins in culture 3.12
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 3.11
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 3.09
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 3.09
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.09
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 3.09
Tyrosine Kinase Inhibitor Cardiotoxicity 3.09
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 3.08
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 3.07
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.07
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 3.06
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 3.03
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.03
MYC dependent mRNA translation shapes gene expression and cell biology 3.03
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 3.03
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 3.03
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.02
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 3.0
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 2.99
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.99
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.97
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.96
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.96
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.96
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.95
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.95
RNA-Sequencing of HepG2 cells treated with TGFBeta 2.93
LncRNA expression profiling of ischemic stroke patients 2.84
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.84
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.84
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 2.83
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.8
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 2.78
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.75
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.75
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 2.74
Expression by CD133+ cells isolated from the adult human exocrine pancreas 2.73
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 2.73
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 2.73
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.72
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 2.69
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 2.68
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 2.67
Expression profiles of the four human major ectodermal lineages 2.65
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.64
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.63
Activity-dependent transcriptional changes in human neurons 2.61
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 2.61
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 2.6
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 2.58
Characterization of human ILC2 subsets 2.56
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.55
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.53
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.5
TAF1 is critical for AE driven leukemogenesis 2.5
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.48
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 2.48
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 2.48
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.47
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 2.46
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 2.42
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 2.41
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 2.4
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.4
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.37
RNA editing in nascent RNA affects pre-mRNA splicing 2.37
Targeted enhancer activation by a subunit of the integrator complex 2.35
The age and genomic integrity of neurons after cortical stroke in humans 2.33
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 2.32
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.31
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.3
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 2.28
SLIGRL-induced gene expression changes in NHEK cells 2.26
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.22
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.22
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 2.18
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.13
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 2.08
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 2.08
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 2.05
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 2.05
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.04
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.03
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.02
Identification of a LIF-responsive replication-competent human β cell 2.01
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 2.0
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.0
Interaction between mitoNEET and NAF-1 in cancer cells 1.95
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 1.94
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 1.94
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.93
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.91
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 1.9
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.88
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.88
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.88
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.87
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.87
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.85
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 1.84
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 1.82
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.82
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.82
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 1.82
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 1.82
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.81
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.81
1.77
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.75
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.75
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 1.72
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.72
RNA-seq analysis upon ARID1B overexpression 1.71
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 1.71
RNA-sequencing 1.7
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.69
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.68
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.67
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.67
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.67
STX4 Over-Expression in Human islets 1.66
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 1.66
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.63
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.62
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 1.6
Human neutrophil genome during PMA- and E. coli encounter-induced activation 1.6
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.59
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.59
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.57
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.55
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.52
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.52
FOXP1 orchestration of ASD-relevant signaling pathways. 1.51
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.51
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.5
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.5
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.48
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.48
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 1.48
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 1.46
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 1.46
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 1.41
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.38
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.37
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.36
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.36
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.35
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 1.34
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.32
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.32
Transcription control by the ENL YEATS domain in acute leukemia 1.32
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.31
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.3
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.29
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.29
PGE2 mediated gene expression changes in human cervical stromal cells 1.27
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.25
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.25
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.25
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.24
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.24
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.23
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.21
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.2
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.19
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.19
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 1.18
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.18
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.18
CircRNAome diversity in human mature B-cells, T-cells and monocytes 1.17
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.16
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.15
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.15
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 1.13
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 1.13
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 1.13
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.12
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.09
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.08
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.07
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.06
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.05
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.05
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.04
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.02
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 1.02
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.99
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.96
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 0.96
LIN28A Over-expression RNAseq 0.95
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.95
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.95
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 0.95
Gene expression signatures of innate lymphoid cells from human blood 0.92
siRNA-mediated knockdown 0.91
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 0.9
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.89
HNRNPM-regulated splicing dependencies in prostate cancer 0.89
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.87
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.86
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.86
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.85
RNA seq comparison between scrambled and shGRP78 cells 0.85
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.85
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.84
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.82
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.82
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.8
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.8
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.8
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.8
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.79
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.79
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 0.78
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 0.78
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.77
In vitro modeling of human germ cell development using pluripotent stem cells 0.77
mRNA expression profile of Lymphocytes 0.77
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.75
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 0.75
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 0.75
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.75
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.75
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.74
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.73
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.72
Redifferentiation of expanded human islet β cells by inhibition of ARX 0.72
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.7
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.69
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.68
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.68
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.68
Gene expression analysis of human hepatocellular cancers 0.67
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 0.67
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.67
Myc activation coordinates gene transcription and protein translation responses 0.66
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.64
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.62
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.6
RNA-seq data 0.59
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.59
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.56
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.55
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.52
Molecular analysis of renal cell carcinoma with unclassfied histology 0.52
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.52
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 0.49
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 0.49
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.48
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.48
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.45
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.42
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 0.42
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.41
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.4
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.39
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.39
Hepatic transcriptome of pediatric hepatoblastoma. 0.38
Metastasis in triple-negative breast cancer 0.38
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.38
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 0.38
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.37
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.37
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.37
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.36
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.36
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.35
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.34
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.33
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.3
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.29
RNA-seq of primary patient AML samples 0.29
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 0.29
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.28
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.26
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.26
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.24
Aging-associated patterns in the expression of human endogenous retroviruses 0.2
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.2
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.2
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.19
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.19
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.19
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.16
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.14
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.14
Human Tfh cell RNA bulk sequencing 0.14
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.13
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.12
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.12
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.12
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.12
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 0.12
BMS-470539 on human synovial fibroblasts 0.11
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.08
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.08
The transcriptome and chromatin accessbility landscape of mammalian germline 0.08
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.07
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.06
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.06
Leucegene: AML sequencing (part 6) 0.05
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.01
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.01
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.01
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.01
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation